The 20 Best Neuroendocrine Tumor Doctors Near Me in Ann Arbor, MI

Dr. Else’s primary appointment is with the Division of Metabolism, Endocrinology and Diabetes. He received his MD degree from the University of Hamburg, Germany. He pursued his clinical training at the University of Hamburg (Residency: Internal Medicine) and the University of Michigan (Residency: Internal Medicine, Fellowship: Endocrinology). His main research interests are the genetics of endocrine tumors. Dr. Else’s clinical practice focuses on the care for patients with benign and malignant endocrine tumors, particularly pheochromocytoma, adrenocortical tumors and neuroendocrine tumors as well as accompanying hormone excess syndromes (e.g Cushing syndrome, primary aldosteronism). Dr. Else has a particular interest in taking care of patients with hereditary syndromes that predispose to the development of endocrine tumors (e.g. Multiple Endocrine Neoplasia (MEN) type 1, MEN2A & MEN2B, Hereditary Paraganglioma Syndrome). He attends the Multidisciplinary Endocrine Oncology Clinic, where patients with tumors receive diagnostic procedures and treatment. In addition he is part of the Cancer Genetics Clinic, which evaluates patients for hereditary syndromes and also facilitates regular exams and surveillance for patients at risk for endocrine tumors. Dr. Else is rated as an Elite provider by MediFind in the treatment of Neuroendocrine Tumor. He is also highly rated in 105 other conditions, according to our data. His clinical expertise encompasses Adrenal Cancer, Adrenocortical Carcinoma, Adrenal Gland Adenoma, Neuroendocrine Tumor, and Thyroidectomy. Dr. Else is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Benjamin Viglianti is a Radiologist and a Nuclear Medicine provider practicing medicine in Ann Arbor, Michigan. He has been practicing medicine for over 17 years. Dr. Viglianti is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Osteopenia, Melorheostosis with Osteopoikilosis, and Melorheostosis. Dr. Viglianti is board certified in Diagnostic Radiology and Nuclear Medicine.

Mishal Mendiratta is a Radiologist practicing medicine in Ann Arbor, Michigan. Dr. Mendiratta is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. She is also highly rated in 40 other conditions, according to our data. Her clinical expertise encompasses Liver Cancer, Fibrolamellar Carcinoma, Visceromegaly, and Cholangiocarcinoma (Bile Duct Cancer).

Daniel Barkmeier is a Radiologist practicing medicine in Ann Arbor, Michigan. Dr. Barkmeier is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. He is also highly rated in 51 other conditions, according to our data. His clinical expertise encompasses WT1-Related Wilms Tumor Syndromes, Thyroid Nodule, Adrenal Cancer, and Renal Cell Carcinoma (RCC). Dr. Barkmeier is board certified in Diagnostic Radiology.

Ashish Wasnik is a Radiologist practicing medicine in Ann Arbor, Michigan. Dr. Wasnik is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Visceromegaly, Alcoholic Cirrhosis, Neuroendocrine Tumor, Penectomy, and Small Bowel Resection. Dr. Wasnik is board certified in Diagnostic Radiology.

Ella Kazerooni is a Radiologist practicing medicine in Ann Arbor, Michigan. Dr. Kazerooni is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. She is also highly rated in 44 other conditions, according to our data. Her clinical expertise encompasses Lung Nodules, Emphysema, Interstitial Lung Disease, Pulmonary Fibrosis, and Transcatheter Aortic Valve Replacement (TAVR).

Isaac Francis is a Radiologist practicing medicine in Ann Arbor, Michigan. Dr. Francis is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, WT1-Related Wilms Tumor Syndromes, Ganglioneuroblastoma, and Synovial Sarcoma.

Dr. Davenport is an internationally recognized expert on the safety and efficacy of radiographic contrast material. He has served on the U.S. Food and Drug Administration Medical Imaging Drugs Advisory Committee, the National Cancer Institute Clinical Imaging Steering Committee, and the American College of Radiology's Committee on Drugs on Contrast Media (current chair). He has numerous national responsibilities, is a co-author on national policy statements, has published over 150 manuscripts, was founder of the Michigan Radiology Quality Collaborative, and is a funded investigator. His primary clinical interests include patient safety, high-value care, and urologic imaging. Dr. Davenport is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Neuroendocrine Tumor, WT1-Related Wilms Tumor Syndromes, Prostatectomy, and Cardiac Ablation.

Elaine Caoili is a Radiologist practicing medicine in Ann Arbor, Michigan. Dr. Caoili is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Visceromegaly, Alcoholic Cirrhosis, Ascites, Neuroendocrine Tumor, and Cardiac Ablation.

Katherine Maturen is a Radiologist practicing medicine in Ann Arbor, Michigan. Dr. Maturen is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. She is also highly rated in 47 other conditions, according to our data. Her clinical expertise encompasses Visceromegaly, Ureterocele, WT1-Related Wilms Tumor Syndromes, and Alcoholic Cirrhosis. Dr. Maturen is board certified in Diagnostic Radiology.

Prasad Shankar is a Radiologist practicing medicine in Ann Arbor, Michigan. Dr. Shankar is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses WT1-Related Wilms Tumor Syndromes, Visceromegaly, Neuroendocrine Tumor, Renal Cell Carcinoma (RCC), and Prostatectomy.

Dr. Clifford S. Cho is the C. Gardner Child Professor of Surgery in the Division of Hepatopancreatobiliary and Advanced Gastrointestinal Surgery at Michigan Medicine.Dr. Cho is an Honors graduate of Brown University and AOA graduate of the Vanderbilt University School of Medicine. He completed his general surgery residency and transplantation immunology postdoctoral research fellowship at the University of Wisconsin, where he served as Chief Administrative Resident. He completed his surgical oncology fellowship at the Memorial Sloan-Kettering Cancer Center, where he served as Chief Administrative Fellow. He joined the faculty of the University of Wisconsin School of Medicine and Public Health in 2006, where he was promoted to Associate Professor with Tenure and named the Ronald and Patricia Kissinger Professor of Surgical Oncology. He served as Chief of the Division of Surgical Oncology, Associate Residency Program Director, and co-Director of the Gastrointestinal Disease Oriented Team in the University of Wisconsin Carbone Cancer Center before moving to the University of Michigan in 2016.Dr. Cho’s academic focus is on hepatopancreatobiliary and gastrointestinal malignancies, cancer immunology, and the mentorship of clinical and research trainees. He has lectured on these academic interests in over 15 national and international visiting professorships, and was named the James IV Traveler in 2014. He has published over 120 peer-reviewed manuscripts and book chapters and currently serves on the editorial boards of Surgery and the Journal of Gastrointestinal Surgery. He is the Principal Investigator of a VA Merit Review-funded cancer immunology laboratory that is working to understand cancer-induced T cell suppression, and to identify novel T cell-based strategies for cancer immunotherapy. His laboratory has been continuously funded since 2006 by extramural support from the Veteran’s Administration, National Institutes of Health, American College of Surgeons, and Central Surgical Association, and is a member of the VA Oncology Merit Review study section. He has held a number of national academic leadership positions and is a member of over 15 surgical societies, including the American Surgical Association, Society of Clinical Surgery, Society of University Surgeons, and Surgical Biology Club II. Dr. Cho is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Pancreatectomy, and Pancreaticoduodenectomy. Dr. Cho is board certified in Surgery.

Dr. Zalupski is an Professor of Medicine in the division of Medical Oncology at the UMMC. He completed medical school, an internal medicine residency and a medical oncology fellowship at Wayne State University in Detroit. Dr. Zalupski's clinical and research interest is in experimental therapeutics of gastrointestinal malignancies and sarcomas. He also serves as the medical director of the Multidisciplinary Pancreatic Cancer Clinic. Dr. Zalupski is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Neuroendocrine Tumor, Familial Pancreatic Cancer, and Pancreaticoduodenectomy. Dr. Zalupski is board certified in Internal Medicine and Medical Oncology.

Dr. Hari Nathan is a board-certified complex general surgical oncologist and Associate Professor of Surgery with Tenure. Dr. Nathan completed both his undergraduate and medical education with honors at The Johns Hopkins University. He also completed advanced training in health services research and was awarded a PhD from The Johns Hopkins Bloomberg School of Public Health. Dr. Nathan completed his clinical residency training in general surgery at The Johns Hopkins Hospital. He subsequently completed a clinical fellowship in complex general surgical oncology at Memorial Sloan Kettering Cancer Center, where he also served as the Chief Administrative Fellow in Surgery. He joined the faculty of the University of Michigan in 2014. Clinical Specialization: Dr. Nathan's clinical focus includes the multi-disciplinary treatment of tumors of the pancreas, liver, bile duct, and stomach. He has particular interests in the treatment of liver metastases from colorectal cancer and directs Michigan Medicine’s Hepatic Artery Infusion Pump (HAIP) Program. He also serves as the Surgical Director of the Multidisciplinary Pancreatic Cancer Clinic, coordinating the efforts of a multidisciplinary team at the busiest pancreatic cancer program in Michigan. Dr. Nathan is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatectomy, and Pancreaticoduodenectomy. Dr. Nathan is board certified in Surgery and Complex General Surgical Oncology.

Kirk Frey is a Neurologist and a Nuclear Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Frey is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Parkinson's Disease, Movement Disorders, Neuroendocrine Tumor, Osteopenia, and Hormone Replacement Therapy (HRT).

Dr. Francis Worden received his medical degree from the Indiana University School of Medicine in 1993. Prior to attending medical school, he worked as a registered pharmacist at a large community hospital in Indianapolis. In 1997, Dr. Worden completed a combined residency in internal medicine and pediatrics at the Detroit Medical Center and finished a medical oncology/hematology fellowship at the University of Michigan. In July 2000, Dr. Worden joined the faculty at the University of Michigan Rogel Cancer Center, where he is currently working as a clinical investigator with both the multidisciplinary head and neck oncology team and the multidisciplinary lung cancer team. Dr. Worden's research interests include organ preservation in head and neck cancer and endocrine oncology. He is the Nancy Wigginton Oncology Research Professor of Thyroid Cancer. Avid competitive swimmer ; cyclist and runner. Dr. Worden is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Throat Cancer, Thyroid Cancer, and Head and Neck Squamous Cell Carcinoma (HNSCC). Dr. Worden is board certified in Medical Oncology.

Dr. Bednar is a faculty member in the Department of Surgery at the University of Michigan.His undergraduate training was done at Princeton University, where he graduated with a Bachelor of Arts degree in molecular biology in 2000. After that he transitioned to the Lewis Katz School of Medicine of Temple University in Philadelphia. Dr. Bednar spent seven years in the combined MD/PhD program where he earned an MD and PhD in Microbiology and Immunology in the laboratory of Dr. Thomas Rogers. His dissertation thesis focused on how human monocytes respond to the complex external environment present during an infection or inflammatory state. After the completion of his medical training he was accepted to the General Surgery Residency program at the University of Michigan. During his time in Ann Arbor, he also spent two years in a postdoctoral research fellowship in the laboratories of Dr. Diane Simeone and Dr. Marina Pasca di Magliano. During Dr. Bednar's research time, he studied the basic biology of pancreatic cancer, which led to his evolving interest in cancer patient care. He finished his clinical training in the Complex General Surgical Oncology Fellowship program at the University of Pittsburgh and was recruited back to the University of Michigan to become a part of the pancreatic cancer research group that has developed here in the past decade. Dr. Bednar is a board-certified general surgeon and currently undergoing board certification for additional specialization of Complex General Surgical Oncology. He is also BLS/ACLS certified.Dr. Bednar's clinical and research effort up to now has been recognized through several awards. He received the Dr. Herman Brown Award for Excellence in the Study of the Art and Science of Surgery from the Department of Surgery, Lewis Katz School of Medicine, Temple University as a recognition for his care of the surgical patients and his research work while he was a medical student. Dr. Bednar's work on pancreatic cancer was recognized and supported by an American College of Surgeons Research Fellowship. He also received the Robert V. Danto Cancer Research Award from the Michigan chapter of the American College of Surgeons for his postdoctoral research work. His work was chosen to be presented at the Owen Wangensteen Surgical Forum during the annual American College of Surgeons meeting in 2013 and received the Best Oral Presentation award at the 24th Annual Moses Gunn Research Conference of the Department of Surgery at the University of Michigan in 2012.Clinical Specialization:Dr. Bednar is a practicing general and oncologic surgeon. His practice encompasses the full gamut of general surgery and complex abdominal and soft tissue surgical oncology. During his fellowship training, he also received specific instruction on the DaVinci robotic surgery platform and hope to continue to support the already-established efforts in this arena. Dr. Bednar is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Neuroendocrine Tumor, Familial Pancreatic Cancer, Pancreatectomy, and Small Bowel Resection. Dr. Bednar is board certified in Surgery and Complex General Surgical Oncology.

Richard Brown is a Radiologist and a Nuclear Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Brown is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), Neuroendocrine Tumor, Mantle Cell Lymphoma (MCL), and Melorheostosis. Dr. Brown is board certified in Diagnostic Radiology, Nuclear Medicine, and Nuclear Radiology.

William Weadock is a Radiologist practicing medicine in Ann Arbor, Michigan. Dr. Weadock is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Synovial Sarcoma, Ureterocele, Visceromegaly, and Undifferentiated Pleomorphic Sarcoma. Dr. Weadock is board certified in Diagnostic Radiology.

Mohamed Sayyouh is a Radiologist practicing medicine in Ann Arbor, Michigan. Dr. Sayyouh is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Lung Nodules, Synovial Sarcoma, Rhabdomyosarcoma Embryonal, and Undifferentiated Pleomorphic Sarcoma. Dr. Sayyouh is board certified in Diagnostic Radiology.